Tirzepatide peptide therapy | Uses, dosage, and safety

Sponsored: Tirzepatide is a novel dual-incretin agonist that was recently approved as a medication for type 2 diabetes (T2D).

By peptides.org

| June 26, 2023, 4:27 p.m.

| Updated: Jan. 23, 2024, 6:24 p.m.

By peptides.org

Donate to the newsroom now. The Salt Lake Tribune, Inc. is a 501(c)(3) public charity and contributions are tax deductible